Clinical Trials
22 trialsNCT06347926 2025-11-18
EVABIOSEIN
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT06721936 2025-04-27
PILME
University of Alcala
Phase NA Recruiting
NCT06891690 2025-03-24
tDCS
Poznan University of Physical Education
Phase NA Recruiting
NCT06828640 2025-02-14
Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment
Centre Hospitalier Universitaire Saint Pierre
Phase NA Recruiting
NCT06822582 2025-02-12
GYVE
Laval University
Phase NA Recruiting
NCT05129332 2024-04-04
Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia
Columbia University
Phase NA Withdrawn
NCT03307044 2023-03-20
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03666819 2023-01-06
Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy
Mayo Clinic
Phase 2 Withdrawn
NCT04868812 2022-09-13
REPLAMOD
IRCCS San Raffaele
Phase NA Completed
NCT03372720 2022-04-22
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03935698 2022-01-27
Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study
Université de Sherbrooke
Phase NA Completed
NCT03257670 2021-09-28
BCLS
University of Cincinnati
Phase NA Unknown
NCT03647189 2021-06-18
Randomized, Controlled Trial With Hybrid Fractional Laser
Sciton
Phase NA Completed
NCT03628092 2020-03-12
LAAVA2
Royal North Shore Hospital
Phase NA Unknown
NCT03714581 2019-07-30
Laser Therapy Following Radiotherapy for Gynecological Cancer
National and Kapodistrian University of Athens
Phase NA Unknown
NCT03738605 2019-07-30
Vaginal Laser Therapy in Breast Cancer Survivors
National and Kapodistrian University of Athens
Phase NA Unknown
NCT02150525 2018-08-09
Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT03185169 2018-07-26
GSM
Alta Bates Summit Medical Center
Phase EARLY_PHASE1 Terminated
NCT00981305 2017-08-07
Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors
Seoul National University Hospital
Phase 3 Completed
NCT01539317 2017-04-14
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
OHSU Knight Cancer Institute
Phase 3 Completed
NCT01697345 2014-01-24
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
Creighton University
Phase EARLY_PHASE1 Completed
NCT01122342 2010-05-13
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
University of Vermont
Phase 1/2 Suspended